Skip to main content
search
Endocrinopatías asociadas a obesidad
Ginecología - ObesidadGinecología - Perfil de paciente y necesidadesInfografías

Endocrinopatías asociadas a obesidad

By julio 25, 2023julio 27th, 2023No Comments

Estimado (a) Dr.(a),

Diversas enfermedades endocrinológicas pueden presentarse con incremento de peso y adiposidad (hipotiroidismo, hipercortisolismo, hipogonadismo y deficiencia de hormona de crecimiento), por lo que se han asociado a intolerancia a la glucosa o diabetes, dislipidemia, hipertensión y mayor riesgo de enfermedades cardiovasculares.

En este taller, principalmente, se expondrán los mecanismos fisiopatológicos que ligan a la obesidad con múltiples trastornos metabólicos.

Material desarrollado por Dr. Julio César Roberto Mayorga Camargo. Médico Cirujano. Especialista en Medicina Interna y Endocrinología. Cédula profesional: 3847204, Cédula especialidad: 6442269 – 6442270.

 

Referencias

  1. Schwartz MW, Seeley RJ, Zeltser LM, Drewnowski A, Ravussin E, Redman LM, et al. Obesity Pathogenesis: An Endocrine Society Scientific Statement. Endocr Rev. 2017; 1;38(4):267-296.
  2. Park HK., Ahima RS. Endocrine Disorders Associated with Obesity. In: Ahima R, editors. Metabolic Syndrome. Springer, Cham; 2015.
  3. Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet. 2017; 23;390(10101):1550-1562.
  4. Danforth E Jr., Horton ES, O’Connell M, Sims EA, Burger AG, Ingbar SH, et al. Dietary‑induced alterations in thyroid hormone metabolism during overnutrition. J Clin Invest. 1979;64:1336‑47.
  5. Knudsen N, Laurberg P, Rasmussen LB, Bülow I, Perrild H, Ovesen L, et al. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab. 2005;90:4019‑24.
  6. Biondi B. Thyroid and obesity: An intriguing relationship. J Clin Endocrinol Metab. 2010; 95:3614‑7.
  7. Tagliaferri M, Berselli ME, Calò G, Minocci A, Savia G, Petroni ML, et al. Subclinical hypothyroidism in obese patients: Relation to resting energy expenditure, serum leptin, body composition, and lipid profile. Obes Res 2001;9:196‑201.
  8. Sanyal D, Raychaudhuri M. Hypothyroidism and obesity:An intriguing link. Indian J Endocr Metab. 2016;20:554-7.
  9. Fazio S, Palmieri EA, Lombardi G, Biondi B. Effects of thyroid hormone on the cardiovascular system. Recent Prog Horm Res. 2004;59:31-50.
  10. Montenegro J, González O, Saracho R, Aguirre R, González O, Martínez I. Changes in renal function in primary hypothyroidism. Am J Kidney Dis. 1996;27(2):195-8.
  11. Gianoukakis AG, Jennings TA, King CS, Sheehan CE, Hoa N, Heldin P, Smith TJ. Hyaluronan accumulation in thyroid tissue: evidence for contributions from epithelial cells and fibroblasts. Endocrinology. 2007;148(1):54-62.
  12. Laurberg P, Knudsen N, Andersen S, Carlé A, Pedersen IB, Karmisholt J. Thyroid function and obesity. Eur Thyroid J. 2012;1(3):159-67.
  13. Adamska A, Raczkowski A, Stachurska Z, Kondraciuk M, Krętowski AJ, Adamski M, Kowalska I, Kamiński KA. Body Composition and Serum Concentration of Thyroid Hormones in Euthyroid Men and Women from General Population. J Clin Med. 2022 Apr 11;11(8):2118.
  14. Samuels MH, Kolobova I, Antosik M, Niederhausen M, Purnell JQ, Schuff KG. Thyroid Function Variation in the Normal Range, Energy Expenditure, and Body Composition in L-T4-Treated Subjects. J Clin Endocrinol Metab. 2017; 1;102(7):2533-2542.
  15. Kaptein EM, Beale E, Chan LS. Thyroid hormone therapy for obesity and nonthyroidal illnesses: a systematic review. J Clin Endocrinol Metab. 2009;94(10):3663-75.
  16. Nieman LK, Biller BMK, Findling JW, Murad H, Newell-Price J, et al. Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline, J Clin Endocrinol Metab. 2015; 100(8): 2807–31.
  17. Hewagalamulage SD, Lee TK, Clarke IJ, Henry BA. Stress, cortisol, and obesity: a role for cortisol responsiveness in identifying individuals prone to obesity. Domest Anim Endocrinol. 2016;56 Suppl:S112-20.
  18. Luijten IHN, Cannon B, Nedergaard J. Glucocorticoids and Brown Adipose Tissue: Do glucocorticoids really inhibit thermogenesis? Mol Aspects Med. 2019;68:42-59.
  19. Morais JBS, Severo JS, Beserra JB, de Oiveira ARS, Cruz KJC, de Sousa Melo SR, do Nascimento GVR, et al. Association Between Cortisol, Insulin Resistance and Zinc in Obesity: a Mini-Review. Biol Trace Elem Res. 2019;191(2):323-330.
  20. Brillon DJ, Zheng B, Campbell RG, Matthews DE. Effect of cortisol on energy expenditure and amino acid metabolism in humans. Am J Physiol. 1995;268(3 Pt 1):E501-13.
  21. Min L. Functional Hypercortisolism, Visceral Obesity, and Metabolic Syndrome. Endocr Pract. 2016;22(4):506-8.
  22. Richard-Eaglin A. Male and Female Hypogonadism. Nurs Clin North Am. 2018;53(3):395-405.
  23. Brown LM, Gent L, Davis K, Clegg DJ. Metabolic impact of sex hormones on obesity. Brain Res. 2010; 2(1350):77-85.
  24. Mayes JS, Watson GH. Direct effects of sex steroid hormones on adipose tissues and obesity. Obes Rev. 2004;5(4):197-216.
  25. Tchernof A, Després JP. Sex steroid hormones, sex hormone-binding globulin, and obesity in men and women. Horm Metab Res. 2000;32(11-12):526-36.
  26. Wake DJ, Strand M, Rask E, Westerbacka J, Livingstone DE, Soderberg S, et al. Intra-adipose sex steroid metabolism and body fat distribution in idiopathic human obesity. Clin Endocrinol. 2007;66(3):440-6.
  27. Gasco V, Caputo M, Lanfranco F, Ghigo E, Grottoli S. Management of GH treatment in adult GH deficiency. Best Pract Res Clin Endocrinol Metab. 2017;31(1):13-24.
  28. Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML. Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline, J Clin Endocrinol Metab. 2011; 96(6): 1587–609.
  29. Berryman, D, Glad, C, List L. The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations. Nat Rev Endocrinol. 2013; 9: 346–56.
  30. Al-Samerria S, Aloqaily B, Negron A, Wondisford FE, Radovick S. Interrupted IGF-1 Feedback in GHRH Neurons and Somatotrophs Results in Impaired Weight Gain and Increased Energy Expenditure. J Endocr Soc. 2021;5(Suppl 1):A52.
  31. Berryman DE, List EO, Sackmann-Sala L, Lubbers E, Munn R, Kopchick JJ. Growth hormone and adipose tissue: beyond the adipocyte. Growth Horm IGF Res. 2011;21(3):113-23.
  32. Kopchick JJ, Berryman DE, Puri V, Lee KY, Jorgensen JOL. The effects of growth hormone on adipose tissue: old observations, new mechanisms. Nat Rev Endocrinol. 2020;16(3):135-46.

 

Material exclusivo para profesionales de la salud.

La información aquí presentada es opinión del ponente.

Material desarrollado con fines de educación médica continua.

Código interno de aprobación: MX22SX00155.

La pubertad en las mujeres

elación de pubertad temprana y obesidad

Síndrome de ovario poliquístico y calidad de vida

impacto de la obesidad en la adolescencia

impacto de la obesidad en la menarca

onquer Obesity Ginecología

Leave a Reply

Close Menu